Member Info for wolfi

With high grade gold intersections spread along 2.7km and proposed drilling targets in the Upper and Lower Zones along strike and below the Carlow resource, there is plenty to be excited about.

Delay's my @rse ;

Drilling starting next week at Titan east.

Great news for investors to see a time table for the next 4 or 5 months, looks like the company are really going for it at Carlow/Titan concentrating their efforts and finances on this one area rather than a scattergun approach of drilling right across their licences.

Blencowe Resources CEO Mike Ralston commented:

"We are entering a pivotal stage for Blencowe as the DFS nears completion and financing discussions gather pace. Orom-Cross will soon be a significantly de-risked, finance-ready graphite project, and we are seeing strong interest from parties aligned to our development and downstream strategy. Resourcing Tomorrow provides an excellent opportunity to showcase the quality and scale of what we've built and to accelerate engagement with potential partners as we move into the next phase."

Well if anyone knows the true value of our licences it is Mark Creasey and him being our largest shareholder Lex certainly won't be sold on the cheap.

Dibs - LSE not allowing me to post link, if you go onto the LEX board on ADVFN the link is there under BurtonD1 last post.

hi dibs -- link below, its in the section developing prospects in the witwatersrand gold basin

**********************************/2025/11/lexington-gold-ltd-12/

Is this new news; " The results of the study, which has been extended in scope indicating expectations for a positive outcome, have just been released to the JV partners for consideration. " Taken from the below paragraph of the article.

A conceptual-level mining study has been commissioned from Bara Consulting to refine the preliminary mine design, set an exploration schedule, and model capital and operating expenses. The results of the study, which has been extended in scope indicating expectations for a positive outcome, have just been released to the JV partners for consideration. Promising initial results would be the basis for the first formal application for a mining licence. With four operating shafts significant infrastructure is already in place at the target mine, greatly reducing potential development costs.

So if my sums are correct they have sold about 8m shares and share price has held up well .

Now we know where the mm's were getting the shares from.

Thanks BurtonD - a good read and a reminder of all that is going on.

If they did actually go it alone, just imagine the size of the dividends that they would be paying out .

Https://www.redeye.se/company/faron-pharmaceuticals/about-analyst

DOUG CASEY: "Mining Stocks - The Most Explosive Opportunity of My Lifetime" ⚡

The legendary mining investor speaks:

"I've been involved in mining for 50 years... I'm actually playing gold mostly through mining stocks, not through gold itself."

Why Miners Now? The Math Doesn't Lie:

✅ Unprecedented Margins: "Producers have all-in sustaining costs of $1,500/oz and gold is $4,000/oz."

✅ Extreme Undervaluation: "Even after their recent run, gold stocks are still at about the LOWEST level in history relative to market capitalization."

✅ Zero Public Participation: "The public is not involved in these things at all... there's no bubble in crappy little penny mining stocks."

The Coming Mania:

🚀 "We've had about five major bull markets... when the crappy little stocks all go 10-to-1 as a group and some stocks go 100-to-1."

🚀 "I've actually had a thousand-to-one shot which has actually happened to me."

Where to Focus:

⚡Smaller Companies: "I like smaller companies because they're more volatile and management is more entrepreneurial."

⚡Silver Miners - The Secret Leverage:

"There's not a lot of pure silver miners... 70-80% of silver is mined as a byproduct."

"Price of silver could go to $200/oz and the amount mined probably wouldn't go up."

The Bottom Line:

"We're just barely in the takeoff stage. When the public piles in, we'll see the crappy little penny stocks go 10-to-1. This is where you make generational wealth."

I took all i could get 300k , nothing available now.

Https://x.com/that_stocks_guy/status/1986362371443486979

It seems pretty clear that a decision has been made to now concentrate on the huge potential that lies in South Africa , so i don't see anymore money being spent on drilling the USA acreage.

Mark Greenwood did say at the beginning of October that if anymore money was needed that he was prepared to support the company.

Looks good :

• advance its South African gold projects, particularly the Jelani JV with Harmony Gold, through technical studies, permitting and certain other ongoing project development activities; and

• undertake initial preparatory work with potentially interested parties regarding the possible divestment or joint venture of its USA gold projects in the Carolinas.

Good to see that there is interest in the USA assets and that LEX are preparing to do a deal on them, also really good to see our directors contributing to the loan so as to avoid dilution.

“The continued recognition of the bexmarilimab program by prestigious congresses like ASH is a testament to the strength and consistency of the data we are generating,” said Dr. Juho Jalkanen, CEO of Faron. “The encouraging data in the challenging mutated TP53 patient population, underscores the potential of bexmarilimab to address a significant unmet need in hematologic malignancies. This marks a significant step forward in our mission to bring novel immunotherapies to patients who currently have very few options.”

Dr. Petri Bono, Chief Medical Officer of Faron, said, “These two datasets provide a compelling, dual narrative for bexmarilimab’s activity that improves patient outcomes. The oral presentation highlights encouraging response rates in TP53-mutated HR-MDS, a notoriously difficult-to-treat disease where standard therapies fall short. Concurrently, the data on transfusion independence not only demonstrates a tangible quality-of-life benefit for patients but also correlates with a better safety profile and hematopoietic recovery. These findings reinforce our belief in bexmarilimab’s unique mechanism to both fight the cancer and support the recovery of the patient’s own blood cell production.”